-
1 Comment
Sysmex Corporation is currently in a long term uptrend where the price is trading 14.3% above its 200 day moving average.
From a valuation standpoint, the stock is 88.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.4.
Sysmex Corporation's total revenue rose by 6.1% to $80B since the same quarter in the previous year.
Its net income has increased by 18.9% to $11B since the same quarter in the previous year.
Finally, its free cash flow grew by 554.6% to $13B since the same quarter in the previous year.
Based on the above factors, Sysmex Corporation gets an overall score of 5/5.
Exchange | TSE |
---|---|
CurrencyCode | JPY |
ISIN | JP3351100007 |
Sector | Healthcare |
Industry | Medical Devices |
PE Ratio | 23.75 |
---|---|
Target Price | 3037.3333 |
Market Cap | 1T |
Dividend Yield | 1.6% |
Beta | 0.82 |
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6869.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025